Pharma-Bio Serv, Inc.
PBSV
$0.51
-$0.09-15.00%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 95.40K | 8.50K | 16.10K | -309.20K | -213.80K |
| Total Depreciation and Amortization | 60.80K | 50.80K | 46.50K | 44.40K | 44.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.90K | -127.10K | 38.60K | -58.40K | -11.10K |
| Change in Net Operating Assets | -504.70K | -361.80K | -22.80K | -347.20K | -520.50K |
| Cash from Operations | -301.60K | -429.50K | 78.40K | -670.30K | -700.70K |
| Capital Expenditure | -4.30K | -- | -157.00K | -1.90K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.22M | 988.30K | 328.50K | 3.69M | -458.90K |
| Cash from Investing | -3.23M | 988.30K | 171.50K | 3.69M | -458.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -17.20K | -- | 0.00 | -1.70K | -2.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.72M | -- | 0.00 | -- | -1.72M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.74M | -- | 0.00 | -1.70K | -1.72M |
| Foreign Exchange rate Adjustments | 51.50K | -19.10K | -2.80K | -7.10K | -19.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.21M | 539.80K | 247.20K | 3.01M | -2.90M |